The case–control comparison of parameters related to oxidative stress showed a significant increase in the activity of antioxidant enzymes SOD and GPx in blood, and a significant decrease in the levels of total SH groups in the prostate cancer patients compared to control (Figure 1). Here, SOD1 is linked to prostate cancer.